AprilBio Co Ltd (397030)

Currency in KRW
43,200
+1,750(+4.22%)
Closed·
397030 is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
40,65044,700
52 wk Range
16,16076,700
Key Statistics
Bid/Ask
43,200.00 / 43,250.00
Prev. Close
41,450
Open
40,650
Day's Range
40,650-44,700
52 wk Range
16,160-76,700
Volume
316.73K
Average Volume (3m)
311.44K
1-Year Change
146.4347%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
397030 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
100,000
Upside
+131.48%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 100,000
(+131.48% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
15/05/2026
EPS / Forecast
9.00 / 45.00
Revenue / Forecast
725.35M / --
EPS Revisions
Last 90 days

Compare 397030 to Peers and Sector

Metrics to compare
397030
Peers
Sector
Relationship
P/E Ratio
−95.9x−16.8x−0.5x
PEG Ratio
0.67−0.480.00
Price/Book
9.9x2.5x2.6x
Price / LTM Sales
1,338.0x11.9x3.0x
Upside (Analyst Target)
141.3%95.2%58.6%
Fair Value Upside
Unlock15.3%10.2%Unlock

AprilBio Co.,Ltd. develops long-acting type biobetter and antibody biologics. The company develops antibody drugs, double antibodies, long-acting antibody drugs, long-acting protein drugs, and ADC-applied antibodies. It is developing various products for use in the treatment of rare diseases, cancer, male infertility, autoimmune and inflammatory diseases. The company was founded in 2013 and is headquartered in Chuncheon-si, South Korea.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1.08M4.63%44.35B
Other Institutional Investors
3.99M17.08%163.49B
Public Companies & Retail Investors
18.27M78.28%749.21B
Total
23.34M100.00%957.05B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Sm-Sino Technology Investment Co., Ltd.4.66%1,087,41044,583,810
JPMorgan Chase & Co.4.64%1,083,61244,428,092

People Also Watch

33,250
074600
-1.34%
11,140
085660
-4.05%
38,800
039200
-1.52%
13,770
300720
0.00%
92,900
064400
-6.16%

FAQ

What Is the AprilBio (KOSDAQ: 397030) Share Price Today?

The AprilBio stock price today is 43,200 KRW.

What Stock Exchange Does AprilBio (397030) Trade On?

AprilBio is listed and trades on the KOSDAQ.

What Is the Ticker (Stock Symbol) for AprilBio?

The stock symbol (also called a 'ticker') for AprilBio is "397030."

What Is the Current AprilBio Market Capitalisation?

As of today, AprilBio (KOSDAQ: 397030) market cap is 970.5B KRW.

What Is AprilBio's (397030) Earnings Per Share (TTM)?

The AprilBio EPS is currently -449 (Trailing Twelve Months).

Is 397030 a Buy or Sell From a Technical Analyst Perspective?

Based on today's AprilBio moving averages and other technical indicators, the daily buy/sell signal for 397030 stock is Strong Sell.

How Many Times Has AprilBio Stock Split?

AprilBio has split 1 times. (See the 397030 stock split history page for full effective split date and price information.)

What is the current trading status of AprilBio (KOSDAQ: 397030)?

As of 10/06/2026, AprilBio (397030) is trading at a share price of 43,200 KRW, with a previous close of 41,450 KRW. The stock has fluctuated within a day range of 40,650 KRW to 44,700 KRW, while its 52-week range spans from 16,160 KRW to 76,700 KRW.

What Is AprilBio (397030) Price Target According to Analysts?

The average 12-month price target for AprilBio is 100,000 KRW, with a high estimate of 100000 KRW and a low estimate of 100000 KRW. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +131.48% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.